Histone-Lysine N-Methyltransferase MLL4 (MLL4) Peptide
MLL4
Host: Synthetic
BP, WB
Catalog No. ABIN980122
Quick Overview for Histone-Lysine N-Methyltransferase MLL4 (MLL4) Peptide (ABIN980122)
Target
MLL4
(Histone-Lysine N-Methyltransferase MLL4 (MLL4))
Source
Synthetic
Application
Blocking Peptide (BP), Western Blotting (WB)
-
-
Characteristics
- This is a synthetic peptide designed for use in combination with anti-MLL4 antibody (Catalog #: ARP33704_T100). It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
-
Purification
- Purified
-
-
-
-
Application Notes
- Each Investigator should determine their own optimal working dilution for specific applications.
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Reconstitution
- Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
-
Concentration
- 1 mg/mL
-
Buffer
- Final peptide concentration is 1 mg/mL in PBS.
-
Handling Advice
- Avoid repeated freeze-thaw cycles.
-
Storage
- -20 °C
-
Storage Comment
- For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
-
-
- MLL4 (Histone-Lysine N-Methyltransferase MLL4 (MLL4))
-
Background
-
MLL4 a protein which contains multiple domains including a CXXC zinc finger, three PHD zinc fingers, two FY-rich domains, and a SET (suppressor of variegation, enhancer of zeste, and trithorax) domain. The SET domain is a conserved C-terminal domain that characterizes proteins of the MLL (mixed-lineage leukemia) family. MLL4 is ubiquitously expressed in adult tissues. It is also amplified in solid tumor cell lines, and may be involved in human cancer
Alias Symbols: HRX2, MLL2, TRX2, WBP7, MLL4
Protein Interaction Partner: ATXN1,PRPF40A,SMAD3
Protein Size: 582 -
Molecular Weight
- 64 kDa
-
Gene ID
- 9757
Target
-
You are here:
